Search This Blog

Tuesday, November 4, 2025

'Mamdani won but has no mandate — it’s up to Hochul to act'

 Zohran Mamdani won a clear victory in the mayoral race Tuesday, but by far less than Democrats usually do; while the numbers aren’t final, at the very least nearly as many New Yorkers voted against him as for him.

That’s no sign of faith in the socialist fantasies he’s selling. He certainly has no mandate to ram through a radical agenda.

New Yorkers seem to know his extremist socialist, pro-crime rhetoric and policies will devastate the city, setting off a historic race for the exits — and a serious, irreversible decline for the city.

More than a third, about 2.8 million residents, said they’d consider bolting if Mamdani won, including 765,000 who said they “definitely” would, reports the Daily Mail, citing a J.L. Partners survey.

Which is why Mamdani’s fellow Democrats — above all, Gov. Kathy Hochul — have a duty to step up, rein him in and head off disaster.

And the fact that so many New Yorkers would support them is all the more reason to do so.

Remember, Democrats wield all the power in Albany — and the city, as a legal matter, needs the state’s permission for most of what Mamdani aims to do (even if the City Council backs him up).

On other fronts, the state can outright overrule the city pretty much any time it wants.

Take Mamdani’s scheme to hike taxes on the rich and corporations: That’s entirely up to Albany.

The only broad-based taxes the city controls are property taxes.

And the income-tax hikes he wants would fuel the exodus, particularly among those being taxed: the rich and the corporations — slamming the state’s tax base even more than the city’s.

Which is why Hochul has vowed to block any new taxes, as she runs for reelection on an “affordability” platform.

Alas, she’s eager to please Mamdani, hoping for his support in next year’s Democratic primary.

In exchange for the socialist’s endorsement, she might cave to at least some of his “tax the rich” demands.

On schools, crime, housing, public transit and more, Mamdani’s agenda is sure to make life more miserable for New Yorkers — if the state backs him.

Hochul and lawmakers can force him to remain responsible for the schools, instead of a de facto transfer of power to the teachers union, which would run them for its own benefit, not the kids’.

They can override his defund-the-police plans and even protect the housing stock by blocking short-sighted rent freezes.

Similarly, the decision to make city buses free, which would dramatically degrade both bus and subway service, is basically up to the gov alone.

True, many voters fell for Mamdani’s fantasy promises; but many others voted for him simply as better than the not-very-credible alternatives.

Hochul & Co. have a duty to save New York from his deceptive, destructive agenda.

They can do so knowing most voters will be behind them.

https://nypost.com/2025/11/04/opinion/zohran-mamdani-won-but-has-no-mandate-its-up-to-kathy-hochul-dems-to-save-the-city/

Depression Treatment Needs A Reset

 by Cara Michelle Miller via The Epoch Times (emphasis ours),

For years, people have been told their sadness was the result of a chemical imbalance—a fixable flaw—like how insulin helps people with Type 1 diabetes.

The Epoch Times/Shutterstock

The “chemical imbalance” theory has shaped mainstream treatment for depression, fueling widespread prescriptions of antidepressants. Yet, psychiatrist and former U.S. Food and Drug Administration (FDA) medical officer Dr. Josef Witt-Doerring said the theory, popularized in the 1950s, has never been proven and lacks scientific backing.

In a recent episode of American Thought Leaders, Witt-Doerring told host Jan Jekielek that relying on the chemical imbalance narrative can lead to overmedication, often with worse—not better—outcomes for patients, and that the way antidepressants are prescribed needs reform.

Origins of the Chemical Imbalance Theory

The chemical imbalance theory first emerged with doctors’ amazement that a tuberculosis drug called iproniazid seemed to energize and lift patients’ moods. Psychiatrists soon tested the drug on people with depression and saw similar improvements.

Iproniazid worked by preventing the breakdown of neurotransmitters—chemical messengers such as serotonin, norepinephrine, and dopamine—thereby increasing their levels. Researchers theorized, based on their observations, that depression must be caused by a shortage of these chemicals in the brain.

The idea revolutionized psychiatry, offering a biological explanation for emotional suffering and paving the way for widespread prescription of antidepressants. For decades, the chemical imbalance theory dominated both medical practice and public perception.

However, once accepted as a medical fact, the theory has begun to crumble.

“A lot of people think that they [antidepressants] work in that they are fixing this imbalance; they are restoring them to a normal state,” Witt-Doerring said. However, growing evidence disputes this.

For instance, a 2022 systematic review published in Molecular Psychiatry found no consistent evidence that low levels of serotonin cause depression. Additional clinical studies have likewise failed to identify reliable differences in neurotransmitter levels between people with and without depression.

“There is no way to differentiate patients who are depressed from those who are not depressed using any objective markers,” he added. “That’s why when you go and see a psychiatrist or a family medicine doctor, they’re not doing blood tests, they’re not scanning your brain—they’re essentially just doing a checklist.”

What Antidepressants Do

Witt-Doerring said that antidepressants don’t correct an underlying defect but instead create a predictable drug effect. For the most common class—selective serotonin reuptake inhibitors (SSRIs)—the effect is often one of emotional blunting or numbing.

SSRIs boost the amount of serotonin in your brain. Serotonin is a chemical that helps manage your mood and emotions. Normally, once serotonin delivers its message, it is taken back into the brain cell that released it. SSRIs slow down that process, so more serotonin stays active between brain cells for a little longer.

Having more serotonin can help even out your mood and ease feelings of anxiety or sadness. However, it can also make emotions feel somewhat flat—you might notice less excitement or joy, as well as less distress—sometimes referred to as emotional numbing or blunting.

For some patients, the dulling of emotional extremes can be therapeutic. For others, it suppresses emotions that need to be processed, leaving underlying issues unresolved.

“If you are in a state where you’re having a lot of anxiety, and you take a drug and it kind of constricts that, it sort of numbs that out, you’re going to feel better,” he said. “And if you’re highly suicidal, you might even say the medication saved your life.”

Hidden Risks of Long-Term Antidepressant Use

Relief derived from antidepressants can come at a cost. Over time, the body adapts to the medication’s effects.

“People become tolerant to them,” Witt-Doerring said, explaining that the drug starts to wear off, doses are increased, and “eventually you’re maxed out—still struggling with the same issues that led you to seek help in the first place.”

To compensate, other medications—mood stabilizers, sleep aids—may be added, a practice known as polypharmacy. However, stacking drugs can also mask, rather than resolve, the underlying problem.

“And this is why you hear that some people are on four, five, six medications,” he said.

When medications lose effectiveness, the body has simply adapted, yet patients are often told they have treatment-resistant depression and are prescribed more drugs—continuing the cycle. The more medications a person takes, the higher the chance of unpleasant or dangerous side effects—and it can become harder to tell which drug is causing which reaction.

Higher doses or multiple drugs may also increase the risk of agitation, impulsivity, or, in rare cases—especially among young people—new or worsening suicidal thoughts during the first few weeks of treatment. The risk is greatest for teens and young adults under 25, which is why antidepressants carry an FDA black box warning for suicidal thinking in this age group.

Meanwhile, life’s problems—stressful relationships, work challenges, or unresolved trauma—often remain unaddressed.

The Dangers of Withdrawal

Many people decide to come off antidepressants at some point—sometimes because they’re feeling better, want fewer side effects, or find the medication isn’t helping as much as it used to.

Stopping antidepressants can be challenging. Some people experience withdrawal effects—such as mood changes, dizziness, or “brain zaps”—when they try to come off the medication. Research suggests that nearly a quarter of people who take SSRIs long-term have withdrawal symptoms lasting more than three months.

Witt-Doerring estimates that 5 to 10 percent of people need medical support to safely stop.

He cited the case of Bryson Burks, a promising college athlete prescribed three antidepressants for pain after a football injury—though he’d never had depression—a practice sometimes used for chronic pain.

Burks—known for his leadership, generosity, and aspirations—appeared happier and stronger after recovering from his injury, according to his mother. However, when instructed to taper off the medications, reducing one pill each week, he developed sudden, extreme mood swings and tragically died by suicide during the fourth week, just before his twentieth birthday. His mother has since spoken publicly about the risks of abrupt or poorly monitored discontinuation of psychiatric medications.

Witt-Doerring also noted that, in rare but serious cases, abrupt medication changes have been linked to extreme agitation or manic reactions. Some high-profile tragedies have prompted questions about whether sudden shifts in psychiatric medication could play a role.

After the 2012 Aurora, Colorado, theater shooting, forensic experts observed that the perpetrator, James Holmes, showed marked behavioral changes after his antidepressant dosage was increased shortly before the attack.

Psychiatrist David Healy, who later interviewed Holmes, said that the timeline warranted closer scientific scrutiny, according to Witt-Doerring. While the courts did not find the medication change to be a legal cause of the violence, the case underscored the importance of careful monitoring whenever antidepressant doses are adjusted or discontinued—particularly for young or vulnerable patients.

Many patients can taper off antidepressants with only temporary discomfort. “Within a couple of months, they have really nasty withdrawal,” but their brains adapt and they move on, Witt-Doerring said. “I would say that they have very healthy, elastic brains.”

A smaller group experiences severe symptoms—insomnia, agitation, tinnitus, cognitive fog—that can last months or even years. For them, a standard two-month taper is too abrupt.

Because doctors rarely expect lingering withdrawal, these symptoms are often mistaken for relapse. Patients are placed back on medication, convinced they cannot live without it, Witt-Doerring said.

In rare but devastating cases, people develop what’s known as protracted withdrawal, a long-term hypersensitivity of the nervous system. “It’s like you’ve had a concussion,” Witt-Doerring said. “It takes 18 months to two years, sometimes longer, for the nervous system to recover.”

Stories like Burks’—who was not Witt-Doerring’s patient—have reshaped how he practices psychiatry. He now runs a tapering clinic specifically for people navigating the withdrawal process, providing careful monitoring and guidance.

His advice to anyone considering coming off antidepressants is to do so gradually—over many months, sometimes years. The safest approach is to proceed slowly and with close support.

Rethinking Care

Today, most psychiatric medications are prescribed by family doctors, gynecologists, and other front-line providers working under intense time pressure. The system often prioritizes quick fixes over long-term wellness.

Witt-Doerring envisions a different care model—embedded in primary care—but focused on “dealing with the real problems.” Patients would receive structured education and group guidance on four areas that drive anxiety and depression: healthy relationships, meaningful engagement—through work, faith, or community—physical health, and substance use.

Imagine a family doctor saying, ‘You’re struggling with relationships and health issues—here’s an assessment, and then you can join a group to learn and talk through these problems with professionals,’” he said.

“That takes the pressure off prescribing medication as the only solution and gives patients real tools to improve their lives.”

https://www.zerohedge.com/medical/why-one-doctor-says-depression-treatment-needs-reset

Stock Selloff Worsens, Bonds Rally on Haven Demand

 


Global stocks extended losses after suffering their steepest drop in nearly a month on concerns over elevated valuations. Treasuries advanced and investors sought the safety of haven currencies such as the yen.

Asian shares fell 2.1% in their biggest intraday loss since April. US equity-index futures weakened, signaling further losses for the S&P 500 and Nasdaq 100 indexes after the gauges pulled back with tech shares hit the hardest. Sentiment was further dented as Super Micro Computer Inc. shares slumped in late trading and Advanced Micro Devices Inc. failed to impress investors with its revenue forecast.

https://www.bloomberg.com/news/articles/2025-11-04/asian-stocks-look-sluggish-after-wall-street-slump-markets-wrap

France investigates Shein and Temu after sex doll scandal



Online retailers Shein, Temu, AliExpress and Wish are being investigated in France in relation to the offence of enabling minors to access pornographic content on their platforms, the Paris prosecutor said on Tuesday.


The country's consumer watchdog had reported the four firms to the prosecution service on Sunday after raising concerns about the sale of childlike sex dolls on Shein's platform over the weekend.

The Paris prosecutor's office told the BBC that the platforms are being investigated over violent, pornographic or "undignified messages" that can be accessed by minors.

The BBC has contacted the companies for comment.


Shein and AliExpress are also under investigation over the dissemination of content related to children that are of a pornographic nature, the office said.

The cases have been referred to Paris' Office des Mineurs, which oversees the protection of minors, the prosecution service added.

On Monday, Shein said it had banned the sale of all sex dolls on its platform worldwide. The Singapore-based retailer also said that it would permanently block all seller accounts related to the illegal sale of the childlike dolls and set stricter controls on its platform.

The French consumer watchdog, the Directorate General for Competition, Consumer Affairs and Fraud Control, had said the sex dolls' description and categorisation left "little doubt as to the child pornography nature" of the products.

The scrutiny of Shein comes as the company, which was founded in China, prepares for the opening on Wednesday of its first permanent physical outlet in France .

Protesters have been seen gathered in front of the Paris department store where Shein is set to open the outlet.

Shein plans to open outlets in other French department stores in cities including Dijon, Reims and Angers.

https://www.bbc.com/news/articles/cx2lppx2jm7o

Global Chip Selloff Erases $500 Billion in Value as Fears Mount

 


The global selloff in semiconductor stocks is accelerating on concern over lofty valuations for some of the artificial intelligence boom’s biggest winners.

South Korea’s equity benchmark Kospi plunged as much as 6.2% on Wednesday, the most since an April hit from US President Donald Trump’s sweeping tariffs, after chipmakers Samsung Electronics Co. and SK Hynix Inc. dragged on the gauge. In Japan, Advantest Corp. dropped nearly 10%, helping pull the Nikkei 225 down more than 4%.

https://www.bloomberg.com/news/articles/2025-11-05/global-chip-selloff-erases-500-billion-in-value-as-fears-mount

The Governor, The CEO, & The FBI: Scandal Threatens New York Hospital

 by Benjamin Weingarten via RealClearInvestigations,

After taking the helm at New York’s financially troubled Nassau University Medical Center late last year, Megan C. Ryan stumbled upon something baffling in the books: a two-decade-long series of transactions engineered by New York State that may have shortchanged the hospital by a staggering $1 billion in matching funds.

As a hospital primarily serving patients on Medicare, Medicaid, or who are uninsured, the medical center qualified for federal matching grants tied to state contributions. Ryan’s discovery indicated that the state was having the medical center itself post its share of the match – for around 20 years at $50 million per year – essentially cheating it out of the state’s matching dollars. “We just couldn’t wrap our heads around how a hospital that serves the poor would be forced to put up tens of millions of dollars” in place of state funds, Ryan told RealClearInvestigations.

Ryan says she called James Dering, previously general counsel of the New York Department of Health, for a legal opinion about the financial arrangement. That opinion indicated it was improper.

What seems like a local tussle over health care has all the trappings of a bigger partisan political fight in the run-up to one of the more important races for governor next year in New York. 

Democrat Gov. Kathy Hochul, who is running for reelection, is the central player in the dispute. The hospital – already at loggerheads with Hochul’s administration over claims the state was unduly withholding needed aid – filed suit last December against New York seeking to be made whole for the $1 billion it believed it was owed.

That litigation would help set in motion a series of events culminating in the takeover of the hospital by Hochul, removing control of the public benefit corporation from the hands of Republican Nassau County executive, Bruce Blakeman; the firing of Ryan and the mass exodus of the hospital’s leaders as the new regime took over; and new legal battles between Ryan and the hospital’s Hochul-appointed leaders.

Nassau University Medical Center’s ousted leaders say the takeover smacks of retaliation for their filing of a lawsuit that exposed alleged malfeasance and political corruption.

Despite Dering’s opinion, the state has argued there was nothing wrong with the hospital putting up the matching funds, and that its interventions in the hospital’s operations have been necessary to rescue a debt-riddled facility that has been hobbled by Republican-linked cronyism and mismanagement in one of the few downstate areas where the GOP is competitive. “It has been for years a Republican patronage pit,” Jay Jacobs, chair of both the state’s and Nassau’s Democratic parties, told Politico. “The place is run by Republican Party operatives.” 

The hospital saga has already drawn scrutiny from both the FBI and Republican congressional investigators – the latter suggesting that the alleged financial scheme is part of a broader effort to save the state’s balance sheet by shifting the Medicaid burden to counties and low-income hospitals. The state’s Medicaid spending is by far the highest in the country, at $4,942 per person.

Republican Rep. Elise Stefanik, who is expected to run against Hochul, has made healthcare one of her key issues, jousting publicly with the governor over their divergent policies and approaches to Medicaid. Adding to the drama is the partisan battle over federal subsidies for rising Obamacare premiums, which is fueling the ongoing federal government shutdown.

The alleged financial shenanigans at the Long Island medical center focus on the convoluted funding mechanisms used to reimburse hospitals for hundreds of billions of care delivered across the country. The saga playing out in Long Island also illuminates the indelibly political nature of healthcare across the country, where two parties often divvy up and spar over control of facilities that are crucial to the lives of voters.

Nassau University Medical Center is a 530-bed Level I Trauma Center located in East Meadow that serves some 270,000 patients each year. It is the only hospital providing care to all comers regardless of their finances, in the suburbs of Nassau County, east of Manhattan. Until Hochul’s state takeover of the hospital this past May, control of the center was split among state leaders, generally Democrats, and local leaders, sometimes Republicans – with county officials retaining the upper hand.

The medical center’s finances have been shaky for years. A report produced by the turnaround firm Alvarez & Marsal concluded in 2020 that the only “potentially sustainable” option going forward would be to reduce the hospital staff by more than 90% – from 3,400 employees to roughly 300 – while eliminating emergency room and medical/surgical inpatient service altogether. 

Under Ryan, the hospital’s performance had improved. Nevertheless, after years of posting losses, the hospital had accumulated a $1.4 billion deficit as of the end of 2024.

While state leaders attributed this shortfall to mismanagement, local and hospital leaders say it is because of the state’s failure to provide necessary financial support – something the state disputes

According to one of the medical center’s lawsuits, its shortfall can be traced to a scheme that worked this way: “[T]he State would instruct the Nassau County Treasurer to instruct the Hospital to make a transfer of funds to the State with the assurance that the funds would be returned to the Hospital – along with the matching federal funds – within 10 days. And indeed, like clockwork, the money was paid to the Hospital within days.”

The state does not deny this description, but it rejects the hospital’s claim that the arrangement was dubious – a “conscious effort to make it appear that the nonfederal portion was coming from the County – when it was in fact coming from the Hospital” – let alone illegal. 

Noting that federal law allows states to cover their non-federal share of Medicaid matching funds through a variety of means, including via intergovernmental transfers from local authorities, New York countered in court filings that counties may put up matching funds and that counties may tap the hospitals themselves for the match. 

Although this would seem to be a straightforward legal issue, the law is murky. Healthcare experts with whom RCI spoke indicated that while intergovernmental transfers are common, they could not opine as to the legitimacy of the ones challenged in the Nassau Center’s case.

The New York State Department of Health and several other county hospitals did not respond to RCI inquiries about whether this arrangement was common practice. 

The courts would never resolve the Nassau University Medical Center dispute. In early May, Hochul effectively seized control of the facility and quashed the hospital’s suits against New York and the hospital’s financial monitor. 

Blakeman, the Republican county executive, called the takeover “illegal” and vowed to file suit.

The takeover had come just weeks after reports had emerged that the FBI was probing the hospital’s underlying allegations of $1 billion in withheld funds, with Blakeman and his handpicked hospital chairman, Matthew Bruderman, cooperating with the investigation.

In July, congressional Republicans running the House Oversight Committee opened a probe into New York’s alleged “abuse of the Medicaid system” through withholding federal Medicaid funds to fill New York budget shortfalls, as well as the alleged years-long $1 billion scheme concerning the Nassau University Medical Center.

A spokesperson for the committee told RCI that there was no update as to its investigation. As for whether other hospitals might be impacted, or analogous efforts were being undertaken in other states, the spokesperson said that the committee believes “this issue is unique to New York State Medicaid.”

In response to inquiries about potential federal probes, the Justice Department and Department of Health and Human Services declined to comment. 

An already complicated saga became even more convoluted this summer with contrasting claims about the hospital’s current finances and its future. Before she was fired in June, Ryan had tendered a letter of resignation in May amid the governor’s takeover that was to be effective July 20. In a separate letter to the hospital’s employees obtained by RCI, Ryan stated that in contrast to claims of mismanagement that had filtered out to the press as the dispute between the hospital and state escalated, the facility had improved its operational and financial performance – including significantly increasing cash reserves – while modernizing and expanding.

“[O]ur team has worked tirelessly to restore financial accountability, clinical excellence, and community trust,” according to the letter. “Despite these gains, powerful interests have spent years trying to undermine this institution and distort my record [through leaks to the press alleging mismanagement]. Their intent is not to improve health care but to consolidate political power, dismantle NUMC’s services, and potentially repurpose our hospital for private development.”

In 2024, as the hospital sought additional New York aid amid accumulated losses totaling several hundred million dollars, the state required that the hospital implement changes to support financial stability, while seeming to endorse Alvarez & Marsal’s 2020 recommendation that the facility be significantly downsized.

Hochul, meanwhile, has undertaken an initiative to repurpose state-owned sites as housing – including easing the ability to create higher-density housing. 

Richard Kessel, the chairman of the hospital’s financial overseer, the Nassau Interim Finance Authority, had previously led the county’s industrial development agency. It had provided economic incentives to aid in several housing projects, repurposing existing land for housing in the vicinity of the medical center.

Seemingly connecting those dots, Bruderman, the former hospital chair, said amid news of Hochul’s upcoming takeover in April that the governor’s efforts aren’t about “saving the hospital, our employees or our patients, but rather a Democratic Party power play. We have documented evidence that Albany intends to shut down the hospital, fire the employees and utilize this land for other purposes for political benefit.”

A Hochul spokesperson said of claims of a hostile takeover, “The board’s restructuring is unequivocally the best possible news for anyone who relies on NUMC.”

“Due to years of gross mismanagement…the hospital is in financial peril,” the spokesperson added. “This is a desperately needed intervention. The state’s priorities for NUMC have always been ensuring quality patient care and achieving financial stability.”

The medical center was reportedly poised to post an $11 million profit in 2025, after posting losses totaling over $140 million in each of the two years prior. 

As for any sort of land deal, a July 2025 opinion piece from a Newsday editorial board member indicated that developers had already begun to reach out to the hospital regarding the nearly 100 acres its facilities cover in a “highly desirable county that has little space to grow.”

“Everything’s on the table except eliminating the safety net hospital,” its Hochul-approved chairman, Stuart Rabinowitz, told the newspaper.

The implication among Hochul’s critics is that high-density housing would most likely benefit Democrats.

Ryan’s attempt to tender her resignation, which was followed by a mass exodus of other hospital leaders, was rejected. Instead, in June, the new board terminated her for cause, denying her severance pay. Ryan notified the hospital that she would seek legal redress.

Before she did so, in August, the hospital filed suit against her seeking $10 million in damages, claiming she had, among other things, engaged in systemic mismanagement, including in authorizing “over $1 million in excessive and improper termination payments” for herself and her exiting colleagues on the way out, and other expenses for reimbursement vastly greater than allowable amounts – including for a lobster dinner on the night one of the executives resigned.

Last month, Ryan countersued, defending her record and claiming the accusations leveled against her were false and defamatory.

Meanwhile, the ousted CEO asserted in her complaint that her successor was hired at a salary roughly 25% higher than her own – which she argues is discriminatory; that the new CEO “has had his hand in prior actual and attempted hospital closures much like the one that now seems imminent” at Nassau University Medical Center; and that the hospital had signed off on $10 million in no-bid contracts in just its first three months under its new board.

While the legal battles intensify, the fate of the safety-net hospital remains unclear.

https://www.zerohedge.com/political/governor-ceo-fbi-scandal-threatens-new-york-hospital

Duffy Warns Parts Of US Airspace Could Grind To Halt Next Week If Gov't Shutdown Drags On

 After weeks of ground stops and flight delays across airports nationwide due to a severe shortage of air traffic controllers amid the ongoing government shutdown, Transportation Secretary Sean Duffy warned today that the worst-case scenario could unfold as early as next week: a partial shutdown of U.S. airspace. 

Duffy warned Tuesday that the Department of Transportation may be forced to close parts of U.S. airspace if the government shutdown continues into next week. As of Tuesday, the shutdown has reached 35 days - a record - with little to no indication that Democrats will agree to a clean resolution to reopen the government. 

"So if, if you bring us to a week from today, Democrats, you will see mass chaos," Duffy warned, adding, "You will see mass flight delays. You'll see mass cancelations, and you may see us close certain parts of the airspace, because we just cannot manage it because we don't have the air traffic controllers."

Duffy noted that thousands of controllers have already missed paychecks, and another $0 pay stub is expected later this week. He said many cannot afford to continue working unpaid, leading to widespread absences, which have triggered ground stops at airports almost daily at this point. 

FAA data shows that about 13,000 air traffic controllers are currently working without pay. The federal agency warned that 80% of the staff in the New York metro area had called out. 

On Tuesday afternoon, more than 2,450 flights traveling within, to, and out of the U.S. were delayed, and over 91 were canceled, according to data from FlightAware.

Last week, airline heads blasted Democrats on the government shutdown, urging the party of crazed leftists to back the Republican-led clean CR. Those airline bosses include:

  • United CEO Scott Kirby, speaking from the White House alongside Vice President J.D. Vance and Transportation Secretary Sean Duffy, called for passage of a "clean CR"—the House GOP's stopgap funding bill that would reopen the government without new spending measures.

  • American, Delta, and Southwest joined United in supporting an immediate extension of current spending levels, warning that the situation was untenable as air-traffic controllers and TSA staff continue to work without pay.

  • Southwest spokesperson Lynn Lunsford said the public "expects and deserves to travel in a system where safety and security employees are paid in a timely fashion."

Besides airlines, the American Federation of Government Employees, representing hundreds of thousands of federal workers, also urged Democrats to back the GOP's clean-CR. 

Anyone planning to travel by plane next week should prepare for widespread delays and cancellations if the shutdown is not resolved by the end of this week.

https://www.zerohedge.com/political/duffy-warns-parts-us-airspace-could-grind-halt-next-week-if-govt-shutdown-drags